Evidence-based medicine (EBM) has long been the backbone of health technology assessment (HTA). Randomised trials feed meta-analyses, guidelines inform HTA, and HTA shapes pricing, reimbursement and adoption. But the last …

1.0 Introduction: from “projects” to the operating model of the NHS Over the past five years, digital health has stopped being a side-project in the English NHS and become part …

Treatment at home has become one of the most ambitious promises in modern UK healthcare. Behind this simple phrase sit two powerful ideas: NHS virtual wards and hospital-at-home programmes — …

Delays between referral and diagnosis are now one of the most serious and systemic patient-safety risks in the NHS elective and cancer pathways. While the NHS introduced the 28-Day Faster …

A scientific, health-economic analysis of why multinationals stall MedTech disruption—and how regulation, reimbursement, and system reform can rebuild an innovation engine. Medical devices shaped every major advance in modern medicine—from …

For years, Italy has carried a peculiar reputation in MedTech circles: admired for its surgeons, respected for its hospitals, but quietly avoided whenever the conversation turned to reimbursement.Executives would talk …